Philips recalls DIVA 24-inch LCD touch displays used with PIC iX system that may generate false alarms, potentially delaying critical patient condition detection. Affected units have specific serial numbers.
If the DIVA touch display generates touch inputs without user interaction, due to possibility of the erroneous acknowledgement of a patient alarm, there is a potential for a delay in the detection of a change in a patient condition which prompted the alarm to generate. Although unlikely, this could potentially result in a patient harm.
Take action
Contact the company
📍Recalling firmPhilips North America Llc222 Jacobs St · Cambridge, MA 02141-2289
✎ GovInfoNow plain-language explainer
Philips is recalling certain DIVA 24-inch LCD touch displays used with their PIC iX central monitoring system. These displays may generate touch inputs without user interaction, which could delay detection of a patient's changing condition and potentially cause harm. The recall is for specific model units with listed serial numbers. Read more at govinfonow.com/recall/56158-philips-diva-24-lcd-touch-display-recall-risk-of-delayed.
“Philips DIVA 24" LCD Touch Display Recall: Risk of delayed patient alarms.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/56158-philips-diva-24-lcd-touch-display-recall-risk-of-delayed. Based on FDA recall #Z-3312-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3312-2024%22&limit=1).
Philips North America Llc recalled the DIVA 24 Inch Widescreen LCD Touch Display used with the Philips PIC iX system central monitoring system, according to the FDA on Feb. 15, 2024. The device may generate touch inputs without user interaction, potentially delaying detection of patient condition changes.
How to tell if you have it
Brand: Philips
Product: DIVA 24 Inch Widescreen LCD Touch Display
Model: RGD2461AMI
Philips Part #: 866126
Serial Numbers: D0122190G0002 through D0122190G0399, D0122220G0404 through D0122220G0681, D0122270G0704 through D0122270G1001, D0122360G1010 through D0122360G1379, D0122380G1423 through D0122380G1764, D0122390G1772 through D0122390G1986
The hazard
If the DIVA touch display generates touch inputs without user interaction, due to possibility of the erroneous acknowledgement of a patient alarm, there is a potential for a delay in the detection of a change in a patient condition which prompted the alarm to generate. Although unlikely, this could potentially result in a patient harm.
Context
GovInfoNow's records show Philips North America Llc has 129 other recalls on record since July 12, 2017. Other recent recalls of similar products include Philips Achieva 3.0T MRI Recall (Aug. 21, 2026), Philips Spectral CT 7500 Scanner Recall (Aug. 18, 2026), and Philips IQon Spectral CT Software 4.7.7.x Recall (Aug. 7, 2026). Additional recent recalls include Philips PIC iX Essentials Software Freezes recall (July 31, 2026), Philips Patient Information Center iX Software Freezes recall (July 31, 2026), and Philips Azurion 7 B20 System Recall (Jan. 26, 2026).
How to tell if you have this one
Check if your DIVA 24-inch LCD touch display has the model number RGD2461AMI and serial numbers listed in the recall (e.g., D0122190G0002, D0122190G0004, etc.). These displays are used with Philips PIC iX central monitoring systems.
Brand
Philips
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Display Model
Verify your DIVA display has model number RGD2461AMI and one of the listed serial numbers.
Contact Philips Support
Reach out to Philips customer support for assistance with the recall.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 10 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide - US Nationwide distribution in the states of CA, IL, ME, NC, NJ, NM, NY, OH, VA, WA and the countries of Australia, Austria, Canada, France, Germany, Italy, Japan, Netherlands, New Zealand, Portugal, Saudi Arabia, United Kingdom.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: California, Illinois, Maine, New Jersey, New Mexico, New York, North Carolina, Ohio, Virginia, Washington.
Recall timeline
FDA published this recall 8 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-3312-2024 (February 15, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-3312-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.